Patient-reported outcomes in a trial of exenatide and insulin glargine for the treatment of type 2 diabetes

BACKGROUND: Patient-reported measures can be used to examine whether drug differences other than clinical efficacy have an impact on outcomes that may be important to patients. Although exenatide and insulin glargine appear to have similar efficacy for treatment of type 2 diabetes, there are several...

Descripción completa

Detalles Bibliográficos
Autores principales: Secnik Boye, Kristina, Matza, Louis S, Oglesby, Alan, Malley, Karen, Kim, Sunny, Hayes, Risa P, Brodows, Robert
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1634743/
https://www.ncbi.nlm.nih.gov/pubmed/17034640
http://dx.doi.org/10.1186/1477-7525-4-80

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1634743/
https://www.ncbi.nlm.nih.gov/pubmed/17034640
http://dx.doi.org/10.1186/1477-7525-4-80

Ejemplares similares